Announcement on Adjusting Distribution Amount per Share in 2024 Annual Profit Distribution Plan
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Adjusting Distribution Amount per Share in 2024 Annual Profit Distribution Plan
Filed with SSE · · 3 pages · Chinese
Release
Earlier from Guobang Pharma
- Announcement on Resolution of the 2024 Annual General Meeting
- Announcement on Wholly-owned Subsidiary Participating in the Establishment of Equity Investment Fund
- Report for Q1 2025
- Announcement on Resolution of the 12th Meeting of the 2nd Board of Directors
- Announcement on Receiving the Letter of Commitment for Buyback Loan
Later from Guobang Pharma
- Announcement on Implementation of Dividend Distribution for 2024
- Announcement on Progress of Wholly-owned Subsidiary Participating in the Establishment of Equity Investment Fund
- Announcement on Wholly-owned Subsidiary's Product Tulathromycin Passing European Union GMP Certification
- Announcement on the Wholly-owned Subsidiary's Participation in the Establishment of the Equity Investment Fund and Completion of the Private Equity Fund Filing
- 2025 Semi-annual Report
Follow Guobang Pharma into a list and get an email when it puts out news.
Follow Guobang Pharma